Company news

Medical Developments International Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

2023 Half Year Presentation

February 23, 2023

2023 Half Year Report (including 4D)

February 23, 2023

2023 Half Year ASX Announcement

February 23, 2023

China Clinical Trials Discontinued

January 17, 2023

Chair and CEO Presentation to Shareholders

October 27, 2022

Security Class Reinstatement to Quotation MVPO

September 1, 2022

Completion of Retail Entitlement Offer

August 29, 2022

FY222 Full Year Results Investor Presentation

August 25, 2022

MVP Announces FY22 Full Year Results

August 25, 2022

FY22 Full Year Accounts

August 25, 2022

Security Class Suspension from Quotation MVPO

August 25, 2022

Prospectus - Entitlement Offer and Options

August 3, 2022

Investor Presentation - $30m Capital Raise and FY22 Guidance

August 3, 2022

MVP Announces $30m Capital Raise and FY22 Guidance

August 3, 2022

MVP signs new Penthrox licensing agreement in Canada

May 10, 2022

US FDA Investor Presentation

March 2, 2022

Green Whistle gets the Green Light - FDA Clears US Trial

March 1, 2022

MVP FY22 Half Year Investor Presentation

February 24, 2022

FY22 Half Year Report and Accounts

February 24, 2022

MVP concludes CSIRO API Continuous Flow Technology Project

February 2, 2022

Company Chair and CEO Address to Shareholders

October 28, 2021

S&P DJI Announces September 2021 Quarterly Rebalance

September 3, 2021

MVP Investor Presentation

August 25, 2021

Preliminary Final Report and Full Year Accounts

August 24, 2021

MVP Announces Outcome of Balance Sheet Review

July 15, 2021

MVP Roadshow Presentation

March 8, 2021

FY21 Half Year Report and Accounts

February 25, 2021

Results of SPP

January 21, 2021

Share Purchase Plan

December 17, 2020

MVP Capital Raising Presentation

December 14, 2020

MVP completes $25m placement

December 13, 2020

EU Transition and Trading Update

December 3, 2020

MVP and MundiPharma cease Australian licensing agreement

October 30, 2020

Chairmans and CEOs Address to Shareholders

October 27, 2020

Appointment of CEO - Brent MacGregor

October 14, 2020

Appointment of Non-Executive Director - Gordon Naylor

October 14, 2020

Medical Developments to take control of EU markets

August 18, 2020

S&P DJI Announces June 2020 Quarterly Rebalance

June 11, 2020

Penthrox approved in Hungary

May 25, 2020

Penthrox approved - Netherlands and Bosnia and Herzegovina

May 4, 2020

Penthrox is approved in Thailand

April 27, 2020

COVID-19 Impact on MVP

March 17, 2020

MVP announces leadership change

March 4, 2020

FY20 HY Report and Accounts

February 18, 2020

Penthrox Marketing Authorisation Application in Russia

December 6, 2019

Penthrox IND approved in China

November 20, 2019

CEO Roadshow Presentation

October 30, 2019

Chairmans Address to Shareholders

October 30, 2019

MVP signs new Manufacturing Development Project with CSIRO

October 28, 2019

Penthrox approved in EUSEM guidelines

October 23, 2019

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 50 decks. Every deck is listed under its year.